Themis Bioscience closes $1.35 million seed financing round - MarketLine Financial Deals

Themis Bioscience closes $1.35 million seed financing round

Themis Bioscience closes $1.35 million seed financing round - MarketLine Financial Deals
Themis Bioscience closes $1.35 million seed financing round
Published Feb 24, 2010
2 pages — Published Feb 24, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Themis Bioscience GmbH, an Austrian biotechnology company, has secured EUR1 million seed financing.

  
Source:
Document ID
MA30866_100820
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Themis Bioscience closes $1.35 million seed financing round" Feb 24, 2010. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Themis-Bioscience-closes-1-35-million-seed-financing-round-2052-39107>
  
APA:
MarketLine Financial Deals. (2010). Themis Bioscience closes $1.35 million seed financing round Feb 24, 2010. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Themis-Bioscience-closes-1-35-million-seed-financing-round-2052-39107>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.